Lysosomal enzymes are synthesized at the rough endoplasmic reticulum as glycosylatedprecursors of high molecular weight. In the endoplasmic reticulum and following in the Golgi complex they undergo a series of modifications that involve cleavage of the aminoterminal signal peptide, disulfide binding, oligoReplacement treatment by the use of pure enzymes in saccharide processing and subunit association.
various lysosomal storage diseases (LSD) has as yet Mannose 6-phosphate residues added in the Golgi not produced permanent clinical improvement. Brady complex serve as a signal for recognition by et al have attempted this in both Gaucher's disease mannose 6-phosphate specific receptors. The receptor-(1) and Niemann-Pick Disease (2) using enzyme made ligand complexes are routed to a prelysosomal acidic from human placenta. Neither has implantation of compartment, where the lysosomal enzymes and recepfibroblasts (3) or amnion-epithelial cells (4) given tors dissociate. The receptors return to the site, any beneficial effects. where they bind lysosomal enzymes (within or distal
In this paper evidence will be produced to show that to the trans-Golgi). A second mannose 6-phosphate a successful bone marrow transplantation (BMT) can receptor dependent pathway ensures receptor-mediated produce an everlasting source of enzyme. When the endocytosis of (exogenous) lysosomal enzymes. The missing enzyme can be demonstrated in the white pathways for receptor-mediated transport of endocells, and that this treatment can be clinically efgenous and exogenous lysosomal enzymes are connected fective. and both involve clathrin-coated vesicles. The lysoso-In Wolman's Disease a satisfactory graft resulted in mal enzymes released from the receptors are transpor-an adequate ievel of acid esterase and acid lipase ted to lysosomes, where they undergo a limited both in the white cells and in liver biopsy along proteolysis, termed maturation. It has become apparent wi th mobilisation and disappearance of cholesterol that defective activity of a lysosomal enzyme in a from the liver (5). lysosomal storage disease can be caused by one of the In GM 1 gangliosidosis a stable white cell engraftfollowing reasons: 1. Defective synthesis of the ment ed to the disappearance of the hepatolysosomal enzyme polypeptide. 2. Defective transport splenomegaly but there was no improvement in the of the newly synthesized lysosomal enzyme to neurological regression, so that the patient died lysosomes. 3. Instability of the lysosomal enzyme fourteen months after the graft, thus not altering polypeptide within the lysosomes. 4 . Deficiency in a the natural history of the disease (6) . cofactor required for activation of the lysosomal In Niemann~Pick Disease type B (non-neurological) a enzyme or for presenting the substrate. 5. Synthesis successful graft has led to some diminution in the of a catalytically inactive lysosomal enzyme polystored sphingomyelin within 80 days of BMT.Hopefully peptide. A single mutation may affect several of the adequate engraftment of normal marrow will conthese parameters, e.g. catalytic activity and stabili-tinue to produce a normal white cell level of the ty or transport properties and stability. missing enzyme, sphingomyelinase, which will lead The lysosomal storage disorders in which different to the disappearance of the hepatosplenomegaly in mutations have been identified by studying the biotime, as has occurred in all other cases of LSD so synthesis and processing of lysosomal enzymes comprise far transplanted. the following disorders: M. Tay-Sachs (1,2), Pompe
Five cases of Gaucher's Disease have been successfully (3,4), fucosidosis (5), metachromatic leukodystrophy engrafted with complete resolution of the hepato-(6), Gaucher (7), Fabry (8) and Maroteaux-Lamy (9) .
splenomegaly, clearing of the lung infiltrate and The analysis of the molecular defects in lysosomal slow improvement in the radiological appearances of storage disorders using -the recently cloned cDNAs for the bones, clinically a very satisfactory result lysosomal enzymes will provide an increased under- At least two classes of genes have been identified, which are important in the pathogenesis of cancer. The first class was originally discovered by the work on acutely transforming RNA tumor viruses and consists of the oncogenes. Activation of these genes by mutation, chromosome translocation or by other means, provides an essential step in the multistage process of malignant transformation. The second class which includes the socalled anti-oncogenes, has been identified in studies of hereditary cancers, in particular Wilms' tumor and retinoblastoma. Whereas oncogenes behave dominantly (one activated copy is sufficient for producing cancer), the antioncogenes show a recessive mode of cancer initiation both alleles have to be inactivated. An example of the first class is the abelson oncogene (c-abl) which seems to play an essential role in chronic myeloid leukemia (CML). CML is Iharacterized by the presence of the Philadelphia (Ph ) chromosome in the1leukemic cells of 96% of all CML patients. The Ph chromosome (22q-) is the result of a reciprocal translocation between chromosome 22 and The availability of human DNA sequences in recomchromosome 9, t(9q34,22qll). previously we described binants has transformed human genetics. There are the localization of the human c-abl oncogene on now approximately five hundred coding gene sequences, chromoyome 9 and demonstrated its translocation to and innumerable localised anonymous probes, cloned the Ph chromosome in CML patients (1) . The cloning and available pure and in unlimited amount. These and analysis of breakpoint fragments revealed that can be used by clinical molecular pathologists to the breakpoints on chromosome 22 all cluster in a study genes in a person-specific way, since any cloned very limited area, the breakpoint cluster region, gene sequence is unique to the person from whom it is bcr (2) . Breakpoints on chromosome 9, however, are isolated. Therefore, all of the heritable parameters scattered over a large area. The detection of a of individuality, whether representing pathological chimeric mRNA (SOber and 3°abl sequences) in the or normal variation, can be studied by comparing gene leukemic cells of CML patients (3, 4) and the cloning sequences.
of chimeric cDNAs from a CML derived cell line KS62 Many of the cloned human coding genes which have (5,6) strongly indicate that bcr and c-abl coding been isolated and characterised to date are also in-sequences are linked by RNA splicing, independent volved in single gene pathology. These include the from the distance between the two genes on the Ph 1 sequences known to be mutated so as to cause known chromosome. These findings suggest an important role and characterised Mendelian disorders, such as thalas· for the altered c-abl product in the generation and/ saemia, PKU or haemophilia. In such cases, the under-or maintenance of CML. lying molecular nature of the defect can be deterStrong evidence for the existence of the second mined, and the probe can be used for population-based class of genes the socal1ed anti-oncogenes comes carrier testing and for unequivocal prenatal diagfrom studies of Wilms' tumor and retinoblastoma. nosis. Other common single gene defects of unknown Both tumors seem to be the result of loss or biochemistry, such as cystic fibrosis and Duchenne inactivation of the two alleles of a wild type gene muscular dystrophy, have been linked either to known located on Ilpl3 in the case of Wilms' tumor (7) DNA coding sequences, or to anonymous DNA probes and 13q14 in retinoblastoma (8) . In the here1itary which are chromosomally localised. In these cases, form of these tumors the first inactivation event is carrier detection and prenatal (or presymptomatic) present in the germ line as a mutation or chromosome diagnosis is only available to informative families deletion, whereas in the non-hereditary cases with living affected members.
(mostly unilaterally affected) the first inactivation A complete map of the human genome will soon be event occurs in the somatic cell. As a result of a children have continued to grow satisfactorily their anatomical bony abnormalities if present, (as in MPS I, II, IV and VI) have not improved after grafting. Thus children with Morguio Disease (MPS IV) (9) and Maroteaux-Lamy Disease (MPS VI) (10) have a disappointing result following BMT, although at first one might have thought they would have been ideal for this treatment, as they have no neurological involvement. There are case reports in the literature of about another thirty inborn errors of metabolism that have been successfully corrected by bone marrow transplantation. (11) 
